MaxCyte, Inc (MXCT): Net earnings per share (EPS TTM)

MaxCyte, Inc. (MXCT) - corporate logo

MaxCyte, Inc. (MXCT) operates within a secure legal framework in the US and EU, supplying equipment to pharmaceutical behemoths. The distribution of net income per share TTM helps assess the quality of the asset, where the value -0.33 expresses the state of the metric. MaxCyte, Inc. (MXCT) dominates the electroporation sector due to its patents and FDA certification, although it faces pressure from major providers of integrated laboratory systems.

MaxCyte, Inc. (MXCT) - Earnings per share for the trailing year from 07/04/2022 to 11/10/2026

Analytical breakdowns and data insights for company MaxCyte Inc. (MXCT)

- stock price and consensus target price:
Stock Price MaxCyte, Inc.|MXCT - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization MaxCyte, Inc.|MXCT - Real Price to Acquire Entire Company
- business book valuation details:
Accounting Value per Share MaxCyte|MXCT - Accounting Value of Company|Market Value to Book Value Ratio maxcyte.com|MXCT - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital MaxCyte, Inc.|MXCT - Long-Term Liabilities to Capital|Short-Term Debt to Capital MaxCyte, Inc|MXCT - Company Aggregate Debt|Debts to Book Capitalization MaxCyte, Inc.|MXCT - Long-Term Debt Volume|Company Short-Term Debts MaxCyte|Quick Ratio maxcyte.com
- earnings and valuation multiples indicators:
MXCT - Net Profit|Expected Profit MaxCyte, Inc.|MXCT - Price to Earnings Ratio|Projected Price to Earnings MaxCyte|MXCT - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple MaxCyte, Inc.|MXCT - Profit before interest, taxes and amortization|Earnings per share for the last twelve months MaxCyte|MXCT - Net earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months maxcyte.com|MXCT - Earnings growth in current year|Earnings growth forecast for next year MaxCyte, Inc.
Fundamental valuation:MaxCyte, Inc. (MXCT)
Manufactured products of MaxCyte Inc.

Business vulnerability to market shocks is mitigated through the analysis of net income per share, which allows for an assessment of real capital generation efficiency without accounting for equity dilution. The high authority of MaxCyte, Inc. (MXCT) in the field of electroporation ensures the stability of this metric; therefore, this rolling annual earnings per share snapshot serves as an objective indicator of fundamental value for the long-term investor.

Competitors of MaxCyte, Inc.

Abbott Laboratories - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters thermofisher.com TMO|GEHC: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Mettler-Toledo|Net earnings per share for the last 12 months WAT|TECH: Earnings per share for the trailing year|Earnings per share for the last twelve months Bruker Corporation (BRKR)|Net earnings per share for the last 12 months azenta.com AZTA|Net earnings per share (EPS TTM) VREX (Varex Imaging Corporation)|Semler Scientific Inc (SMLR) - Net earnings per one share for the last twelve months|Butterfly iQ - Net earnings per share (EPS TTM)|MLAB (Mesa Laboratories Corp.) - Earnings per share for the last 12 months|QSI: Net earnings per share (EPS TTM)|NNOX - Net earnings per share for the last four quarters|QTRX (Quanterix) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months 908 Devices Inc (MASS)|Net earnings per share (EPS TTM) CV|Net earnings per share (EPS TTM) rapidmicrobio.com (RPID)|Earnings per share for the last twelve months Seer, Inc. SEER|hyperfine.io - Earnings per share for the last twelve months|FONR: Net earnings per share for the last 12 months|Earnings per share for the trailing year DXR (Daxor Corporation)|MDAI: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Organovo Holdings Inc. (VIVS)|Earnings per share for the last twelve months Aclarion|AKYA - Net earnings per share for the trailing year|Net earnings per share for the last 12 months THMO (ThermoGenesis Holdings)|Net earnings per share (EPS TTM) talis.bio (TLIS)|Net earnings per share (EPS TTM) TTOO (T2 Biosystems, Inc)